141 related articles for article (PubMed ID: 26793883)
1. [Screening for prostate cancer: clinical significance and future perspectives].
Ito K; Suzuki K
Nihon Rinsho; 2016 Jan; 74(1):72-8. PubMed ID: 26793883
[TBL] [Abstract][Full Text] [Related]
2. [Screening for prostate cancer: present status and future perspectives].
Ito K
Nihon Rinsho; 2014 Dec; 72(12):2198-203. PubMed ID: 25518358
[TBL] [Abstract][Full Text] [Related]
3. [Future perspectives on screening for prostate cancer - an experienced Urologist's viewpoint].
Ito K
Gan To Kagaku Ryoho; 2014 May; 41(5):545-52. PubMed ID: 24917001
[TBL] [Abstract][Full Text] [Related]
4. [Screening for prostate cancer: an up date].
Ito K
Gan To Kagaku Ryoho; 2012 Jan; 39(1):33-7. PubMed ID: 22241351
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific antigen-based screening for prostate cancer: evidence, controversies and future perspectives.
Ito K
Int J Urol; 2009 May; 16(5):458-64. PubMed ID: 19341365
[TBL] [Abstract][Full Text] [Related]
6. [Active surveillance: current status and future perspectives].
Kakehi Y
Nihon Rinsho; 2014 Dec; 72(12):2204-11. PubMed ID: 25518359
[TBL] [Abstract][Full Text] [Related]
7. Prostate-specific antigen: does the current evidence support its use in prostate cancer screening?
Duffy MJ
Ann Clin Biochem; 2011 Jul; 48(Pt 4):310-6. PubMed ID: 21525152
[TBL] [Abstract][Full Text] [Related]
8. Early detection, PSA screening, and management of overdiagnosis.
Borza T; Konijeti R; Kibel AS
Hematol Oncol Clin North Am; 2013 Dec; 27(6):1091-110, vii. PubMed ID: 24188254
[TBL] [Abstract][Full Text] [Related]
9. Prostate specific antigen best practice statement: 2009 update.
Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P
J Urol; 2009 Nov; 182(5):2232-41. PubMed ID: 19781717
[TBL] [Abstract][Full Text] [Related]
10. Prostate Cancer Screening and the Associated Controversy.
Tabayoyong W; Abouassaly R
Surg Clin North Am; 2015 Oct; 95(5):1023-39. PubMed ID: 26315521
[TBL] [Abstract][Full Text] [Related]
11. Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screening.
Ito K; Oki R; Sekine Y; Arai S; Miyazawa Y; Shibata Y; Suzuki K; Kurosawa I
Int J Urol; 2019 Oct; 26(10):956-970. PubMed ID: 31183923
[TBL] [Abstract][Full Text] [Related]
12. PSA in screening for prostate cancer: more good than harm or more harm than good?
Duffy MJ
Adv Clin Chem; 2014; 66():1-23. PubMed ID: 25344984
[TBL] [Abstract][Full Text] [Related]
13. [Screening for prostate cancer].
Ito K
Nihon Rinsho; 2010 Oct; 68(10):1947-52. PubMed ID: 20954344
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen screening for prostate cancer in older men in the United States of America.
Black A; Berg CD
Gerontology; 2012; 58(4):331-6. PubMed ID: 22343605
[TBL] [Abstract][Full Text] [Related]
15. Evolution and immediate future of US screening guidelines.
Greene KL; Punnen S; Carroll PR
Urol Clin North Am; 2014 May; 41(2):229-35. PubMed ID: 24725485
[TBL] [Abstract][Full Text] [Related]
16. Updated Japanese Urological Association Guidelines on prostate-specific antigen-based screening for prostate cancer in 2010.
;
Int J Urol; 2010 Oct; 17(10):830-8. PubMed ID: 20825509
[TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer with PSA testing: current status and future directions.
Croswell JM; Kramer BS; Crawford ED
Oncology (Williston Park); 2011 May; 25(6):452-60, 463. PubMed ID: 21717898
[TBL] [Abstract][Full Text] [Related]
18. Prostate-specific antigen screening, why have the guidelines changed?
Sountoulides P; Moutzouris G
Expert Rev Anticancer Ther; 2014 Nov; 14(11):1277-81. PubMed ID: 25306859
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen best practice statement: 2009 update.
Greene KL; Albertsen PC; Babaian RJ; Carter HB; Gann PH; Han M; Kuban DA; Sartor AO; Stanford JL; Zietman A; Carroll P;
J Urol; 2013 Jan; 189(1 Suppl):S2-S11. PubMed ID: 23234625
[TBL] [Abstract][Full Text] [Related]
20. Screening for prostate cancer remains controversial.
Stark JR; Mucci L; Rothman KJ; Adami HO
BMJ; 2009 Sep; 339():b3601. PubMed ID: 19778971
[No Abstract] [Full Text] [Related]
[Next] [New Search]
